![]() |
|
|
Vol. 292, Issue 3, 982-987, March 2000
Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences,
Chiba University, Chiba, Japan
Diphenylamine is a common structure of nonsteroidal anti-inflammatory
drugs (NSAIDs) to uncouple mitochondrial oxidative phosphorylation and
to cause a decrease in hepatocellular ATP content and hepatocyte injury. The mechanism for acute cell injury induced by diphenylamine and its structurally related NSAIDs was investigated with rat liver
mitochondria and freshly isolated hepatocytes, focusing on the relation
to the uncoupling of oxidative phosphorylation. Incubation of
mitochondria with diphenylamine as well as mefenamic acid and
diclofenac caused pseudoenergetic mitochondrial swelling, indicating
that these compounds induce mitochondrial membrane permeability
transition. Diphenylamine also caused changes in safranine-binding
spectra to mitochondria that was energized by succinate oxidation. This
spectral shift indicates the loss of mitochondrial membrane potentials,
which is known as one of the characteristics for uncouplers of
oxidative phosphorylation, and also was caused by mefenamic acid and
diclofenac. Incubation of hepatocytes with mefenamic acid, diclofenac,
and diphenylamine diminished cellular ATP content, followed by leakage
of lactose dehydrogenase from hepatocytes. Fructose, a low
Km substrate for glycolysis, partially
protected against the ATP depletion and hepatocyte injury induced by
these compounds. Further addition of oligomycin, which blocks ATPase,
pronounced the protection against cell injury. These results suggested
that decreases in cellular ATP content, mainly caused by uncoupling of
mitochondrial oxidative phosphorylation, were responsible for acute
hepatocyte injury induced by diphenylamine and structurally related NSAIDs.
This article has been cited by other articles:
![]() |
W. Dou, S. Thompson-Jaeger, S. J. F. Laulederkind, J. W. Becker, J. Montgomery, E. Ruiz-Bustos, D. L. Hasty, L. R. Ballou, P. S. Eastman, B. Srichai, et al. Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections Am J Physiol Renal Physiol, July 1, 2005; 289(1): F49 - F60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salvatella, I. Rossi, J. C. Del Valle, Y. Gutierrez, C. Pereda, B. Samper, and J. E. Feliu Inhibition of acid secretion by the nonsteroidal anti-inflammatory drugs diclofenac and piroxicam in isolated gastric glands: analysis of a multifocal mechanism Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G711 - G721. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O'connor, P.I. Dargan, and A.L. Jones Hepatocellular damage from non-steroidal anti-inflammatory drugs QJM, November 1, 2003; 96(11): 787 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Mingatto, T. Rodrigues, A. A. Pigoso, S. A. Uyemura, C. Curti, and A. C. Santos The Critical Role of Mitochondrial Energetic Impairment in the Toxicity of Nimesulide to Hepatocytes J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grosse-Siestrup, J. Pfeffer, V. Unger, S. Nagel, C. Witt, A. Fischer, and D. A. Groneberg Isolated Hemoperfused Slaughterhouse Livers as a Valid Model to Study Hepatotoxicity Toxicol Pathol, October 1, 2002; 30(6): 749 - 754. [Abstract] [PDF] |
||||
![]() |
E. Fosslien Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67. [Abstract] [Full Text] [PDF] |
||||